Is Axsome Therapeutics, Inc. overvalued or undervalued?

Sep 20 2025 06:03 PM IST
share
Share Via
As of August 9, 2022, Axsome Therapeutics is considered a risky investment due to its high price-to-book value of 103.56 and negative earnings metrics, despite a strong year-to-date return of 40.21%.
As of 9 August 2022, the valuation grade for Axsome Therapeutics, Inc. moved from does not qualify to risky, indicating increased caution regarding its investment potential. The company appears overvalued, particularly given its high price-to-book value of 103.56 and negative earnings metrics, such as an EV to EBITDA ratio of -23.34 and an ROE of -464.66%. In comparison, BioMarin Pharmaceutical, Inc. has a fair valuation with a P/E of 15.17, while BridgeBio Pharma, Inc. is also classified as risky with a P/E of -14.12.

Despite a strong year-to-date return of 40.21% compared to the S&P 500's 12.22%, the overall financial metrics suggest that Axsome Therapeutics is not a sound investment at its current valuation levels.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is Axsome Therapeutics, Inc. overvalued or undervalued?
Jun 25 2025 08:38 AM IST
share
Share Via
What does Axsome Therapeutics, Inc. do?
Jun 22 2025 06:23 PM IST
share
Share Via
How big is Axsome Therapeutics, Inc.?
Jun 22 2025 05:48 PM IST
share
Share Via